Proactive Investors - Run By Investors For Investors

Integumen appoints two industry heavy-hitters to senior management team

Paul Ryan has been appointed as the company’s head of enterprise sales at Labskin AI, while Colin O’Sullivan joins as chief information officer, a position he previously held at the Australian Medical Association
petri dish
Integumen has now moved into its new, state-of-the-art offices in Cork, Ireland

Integumen PLC (LON:SKIN) shares rose on Thursday as the cosmetics testing group said it has added two industry veterans to its senior management team.

Paul Ryan has been appointed as the company’s head of enterprise sales at Labskin AI – the digital extension to Integumen’s lab-grown skin which helps cut the cost of the testing process in half.

READ: Integumen seeing commercial traction for Labskin AI testing product

Ryan has previously managed strategic partnering programmes with companies such as Siemens, Microsoft and IBM. He joins from 8 West CONsulting where he was head of business development, working with clients including Avon and Estee Lauder.

Integumen has also brought in Colin O’Sullivan as its chief information officer, a position he previously held at the Australian Medical Association.

Integumen said O’Sullivan brings extensive cross-platform software experience in medical and science applications ranging from enterprise applications, cloud computing, artificial intelligence, IT operations, customer experience and development operations.

During his six-year stint at the AMA, he was responsible for “transforming” the group’s online business.

New guys will help drive growth

“We are delighted and fortunate to add these two exceptional individuals to the Integumen team,” said chief executive Gerard Brandon.

“Under Paul's guidance, the sales team will advance the growth of Labskin AI by leveraging the existing sales, marketing and distribution channels of the Labskin laboratory services.”

He added: “Colin's Australian continent AI and IT operational expertise ensures Labskin AI has an architect capable of building out continent-wide bases to deliver a robust global infrastructure.”

New offices and warrant exercise

In the same statement, Integumen confirmed it has moved into its new “state-of-the-art” offices in Cork, Ireland following the recent acquisition of RinoCloud.

CEO Brandon said: “Our new offices in Cork, Ireland, bring the core digital and enterprise sales teams together and are located close to many US and EU pharmaceutical corporations that fit our client target profiles. This expansion adds another exciting new chapter for Integumen.”

In a separate stock exchange announcement, the AIM-quoted company confirmed a shareholder had exercised warrants over 2.5mln shares, bringing in £37,500.

In afternoon trading, shares in Integumen were 5.2% higher at 2.43p.

 -- Adds share price --

View full SKIN profile View Profile

Integumen Timeline

Big Picture
May 21 2019

Related Articles

Sativa
June 07 2019
Geremy Thomas, founder and chief executive of Sativa, said the company has "delivered expeditiously on its investment promise to the market"
researcher
April 30 2019
We take a look at a company with a unique approach to drug development that may ultimately help big pharma replenish its pipeline
harley street
May 10 2019
Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use